AstraZeneca shares drop after company announces 'routine' safety pause in coronavirus vaccine trial

AstraZeneca shares tumbled in after-hours trading Tuesday after the company said its late-stage trial for a potential coronavirus vaccine had been put on hold due to safety concerns.